The Anesthetics Market is expected to register a CAGR of 3.32% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
The report is segmented by Drug Type (General Anesthesia Drugs, Local Anesthesia Drugs); Route Of Administration (Inhalation, Injection, Other Routes Of Administration); Application (General Surgeries, Plastic Surgery, Cosmetic Surgeries, Dental Surgeries, Other Applications). The global analysis is broken down at the regional level and for major countries. The market evaluation is presented in US$ for the above segmental analysis.
Purpose of the ReportThe report Anesthetics Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Anesthetics Market Segmentation
Drug Type- General Anesthesia Drugs
- Local Anesthesia Drugs
- Inhalation
- Injection
- Other Routes Of Administration
- General Surgeries
- Plastic Surgery
- Cosmetic Surgeries
- Dental Surgeries
- Other Applications
Strategic Insights
Anesthetics Market Growth Drivers- Increasing Surgical Procedures: A prominent growth factor in the anesthesia market is the globalization of surgical procedures. As humanity gets older, more and more people will develop chronic conditions such as cardiovascular diseases, cancer, and musculoskeletal conditions that must be surgically treated. Less common are the more complicated surgeries – spinal conditions, and orthopedic issues. The corresponding increase in the requirement of anesthetics for such surgeries. More and more, less invasive surgeries such as laparoscopies and endoscopic surgery are becoming more common, and they require regional anesthesia or local anesthetics, making it even more important to use safe and effective anesthetics. Anesthesiologists’ job is to provide patients with safe and rapid recovery from anesthesia. The growing number of elective and emergency surgeries in the entire world is driving the growth of this market directly. And aging populations in the developed and developing world drive the surgical volume. Hence, surgical anesthetics are now fundamental to the success of patients, and this has increased the market.
- Advancements in Anesthetic Drug Formulations: New anesthetic drug formulations are the continuous advancement in the growth of the anesthetics market. The new anesthetics are quicker to take effect and less time to recover, making the surgery safer and more efficient. Such advancements allow for minimal complications, which is a big problem in the operating room. Drugs such as propofol and desflurane, for instance, are being optimized for better control and recovery, and so are becoming wildly attractive to doctors. And there are further opioid-sparing anesthetics being developed for the opioid crisis. Alternative opioids (acetaminophen and regional anesthetics, for example) are being introduced to prevent opioid dependence. Such drug delivery improvements add to safety and ease of use, increasing demand. New anesthetics with fewer side effects and shorter healing times will help drive the exponential growth of current anesthesia techniques.
- Growing Focus on Pain Management: Growing attention to pain during and after surgery is another market driver for anesthetics. Pain relief has become a factor for physicians and surgeons alike who want the best surgical outcomes. With the advent of post-operative pain programs, which hope to curtail opioid abuse, the prevalence of regional anesthesia and nerve blocks has been upped. More consumers prefer alternatives to opiate pain management, driving the demand for safer anesthetics. Spinal anesthesia, epidural anesthesia, and peripheral nerve blocks are on the rise because they provide permanent pain relief and cut down on opioid use. The transition is creating a need for more powerful anesthetics that manage pain in surgical procedures and postoperatively. The anesthetics market is increasingly increasing due to the healthcare sector’s shift to whole-person care, making pain a vital area of focus.
- Rising use of Ambulatory Surgery Centers (ASCs): The one trend in the anesthetics market is the rising adoption of ambulatory surgery centers (ASCs). These centers specialize in providing discharge on the same day, which is less invasive and often under local anesthesia or light sedation. Such increasing outpatient surgeries are motivated by economics, ease of access, and surgical technology. There are Cosmetic surgeries, GI surgeries, and joint replacements all now conducted in ASCs, which typically administer regional anesthesia or conscious sedation to keep patients comfortable and fast. With the rise of ASCs, the need for anesthesia products specifically for them is on the rise. Rapid-acting, short-recovery anesthetics, and local anesthetics are demanded anesthetics. Such transition from inpatient to outpatient environment is expected to continue, providing huge growth opportunities for the anesthetics market, especially for products whose promise is quick recovery and fewer side effects. ASCs are a cost-effective and user-friendly alternative to surgery, and this is fueling demand for effective anesthesia solutions and boosting the market.
- Rise in Non-Opioid Anesthesia Alternatives: Growing Amidst the opioid crisis, one of the major changes in the anesthetic industry is non-opioid anesthesia alternatives. Traditional anesthesia usually consists of opioids for postoperative pain. But as more and more people realize the risk of opioid addiction, an attempt is made to find anesthetics that deliver efficient pain relief without the need for opioids. Regional anesthesia, nerve blocks, and non-opioid pain relief drugs such as acetaminophen and gabapentinoids are also becoming more commonplace in the clinic. With these opioid-saving anesthetics, not only is dependence reduced, but healing and side effects are lessened. With more people using opioid-free anesthesia protocols, pain management is changing for the better, and is now safer and more sustainable. With a growing preference for non-addictive, safer anesthetics, the opioid-free anesthesia solutions’ share is anticipated to increase significantly. Medical experts are adopting them to reduce opioid use and deliver healthier patients, which will ensure that the anesthetics market is expected to expand in the future.
- New Technology In Anesthesia Delivery System: The latest technology in anesthesia delivery systems is completely revolutionizing the anesthesia market. The machines that deliver smart anesthesia with AI algorithms and advanced monitoring are increasing the accuracy and safety of perioperative anesthetic. They can even adjust anesthesia during surgery based on real-time vital signs data, keeping patients stable during surgery. It’s also getting popular to perform surgery using robots, whose anesthetics have to be precise in difficult operations. Through real-time data analytics in anesthesia, anesthesiologists are better able to monitor patient responses and prevent unnecessary complications and quicker recovery times. AI technologies are also better at predicting patient responses to anesthesia so that care for the patient can be personalized. It’s this evolution towards smarter and more efficient anesthesia delivery systems that will result in huge growth for the anesthetics market as it results in better patient outcomes and increased surgical efficiency.
- Expansion of Anesthesia Options for Pain Control: The increasing pain relief in chronically ill patients such as arthritis, neuropathic pain, and cancer is an attractive market for anesthetics. Opioids were and are the standard of care for postoperative and chronic pain. But, because of the opioid epidemic, the world has moved to opioid-free anesthesia. Regional anesthesia, nerve blocks, and epidural anesthesia are increasingly available as alternatives to opioid addiction and to effective pain management. With chronic pain soaring, this is leading to the search for permanent anesthesia drugs with prolonged pain relief that don’t come with the complications of opioids. What’s more, patients in the process of minor surgery are choosing to be anesthetized with local anesthetic or conscious sedation for faster recovery and fewer side effects. Firms that invest in opioid-sparing anesthesia will be able to meet the demand for non-narcotic, safe pain relief. This opportunity is especially urgent in countries with an opioid addiction epidemic, and where clinicians desperately want to find other ways to treat pain.
- Personalized Anesthesia for High-Risk Patients: Personalized anesthesia is a market that is fast booming, especially for geriatrics, pediatrics, and multiple-comorbidity patients. These patient populations are usually particularly special because of their particular physiology. For instance, older patients might have impaired organ function, and therefore doses of anesthesia need to be modified. In the same way, pediatric patients have different metabolic and weight needs, so anesthesia needs to be custom-tailored. Personalized anesthesia is the approach that considers individual patient conditions — age, weight, history, and even genetic background — in deciding the right dose and risk levels. As precision medicine becomes a reality, healthcare providers are now more interested in tailoring anesthetics, for instance, to each patient. Pharmacogenomics can now better predict the response of patients to anesthesia and give clinicians the drugs they need, in the right doses. This personalization is resulting in a demand for more responsive and precise anesthesia solutions, especially for the most vulnerable patients. The companies able to innovate better, more personalized anesthetics and delivery systems will stand a good chance of acquiring this increasing market share.
- Digital Integration of Anesthesia Management: Digital integration of anesthesia management is one of the big opportunities in the market. Artificial intelligence-based anesthesia machines, intelligent monitoring devices, and real-time data collection are changing the face of anesthesia. These systems ensure anesthesia is administered more precisely and effectively by keeping a close eye on patient vitals and prescribing precise doses in real time. Smart anesthesia machines with AI algorithms can assess and predict the level of anesthesia depending on a patient’s requirements to ensure better outcomes and fewer errors. In addition, robot-assisted surgery and minimally invasive procedures drive the need for anesthesia that’s more precise and controlled. As the medical industry becomes more automated and digital, anesthesia vendors who focus on next-generation technologies will stand to reap the rewards of growing demand for real-time monitoring and precise anesthesia. Growth in the development of minimally invasive surgeries that are fast in recovery times and less hazardous under anesthesia will further propel the market. Then there are the health care providers, who adopt more telemedicine and remote patient monitoring services which also use anesthesia technologies to provide patients safety and productivity. This technological development leaves a lot of room for expansion for companies that can provide advanced anesthesia management systems to boost patient care and efficiency.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Anesthetics Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Anesthetics Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?

Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities

Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
This text is related
to segments covered.

Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
This text is related
to country scope.
Frequently Asked Questions
The Anesthetics Market is estimated to witness a CAGR of 3.32% from 2025 to 2031.
The major factors driving the Anesthetics Market are Increasing Surgical Procedures, Advancements in Anesthetic Drug Formulations, and Growing Focus on Pain Management.
Future trends in the Anesthetics Market are Growth of Ambulatory Surgery Centers (ASCs), Rise in Non-Opioid Anesthesia Alternatives, Technological Innovations in Anesthesia Delivery Systems.
Some players operating in the market are Baxter, Hospira, Abbott Laboratories, AstraZeneca, F. Hoffmann-La Roche AG, B. Braun Melsungen AG, AbbVie Inc., Boehringer Ingelheim International GmbH, Eisai Co. Ltd, Fresenius SE & Co. KGaA
The report can be delivered in PDF/PPT format; we can also share an excel datasheet based on the request.
Some customization options available based on the request are an additional 3–5 company profiles and a country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation# as our team would review the same and check the feasibility.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Anesthetics Market - By Drug Type
1.3.2 Anesthetics Market - By Route Of Administration
1.3.3 Anesthetics Market - By Application
1.3.4 Anesthetics Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ANESTHETICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ANESTHETICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. ANESTHETICS MARKET - GLOBAL MARKET ANALYSIS
6.1. ANESTHETICS - GLOBAL MARKET OVERVIEW
6.2. ANESTHETICS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. ANESTHETICS MARKET - REVENUE AND FORECASTS TO 2028 - DRUG TYPE
7.1. OVERVIEW
7.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
7.3. GENERAL ANESTHESIA DRUGS
7.3.1. Overview
7.3.2. General Anesthesia Drugs Market Forecast and Analysis
7.3.3. Propofol Market
7.3.3.1. Overview
7.3.3.2. Propofol Market Forecast and Analysis
7.3.4. Sevoflurane Market
7.3.4.1. Overview
7.3.4.2. Sevoflurane Market Forecast and Analysis
7.3.5. Desflurane Market
7.3.5.1. Overview
7.3.5.2. Desflurane Market Forecast and Analysis
7.3.6. Dexmedetomidine Market
7.3.6.1. Overview
7.3.6.2. Dexmedetomidine Market Forecast and Analysis
7.3.7. Remifentanil Market
7.3.7.1. Overview
7.3.7.2. Remifentanil Market Forecast and Analysis
7.3.8. Midazolam Market
7.3.8.1. Overview
7.3.8.2. Midazolam Market Forecast and Analysis
7.3.9. Other General Anesthesia Drugs Market
7.3.9.1. Overview
7.3.9.2. Other General Anesthesia Drugs Market Forecast and Analysis
7.4. LOCAL ANESTHESIA DRUGS
7.4.1. Overview
7.4.2. Local Anesthesia Drugs Market Forecast and Analysis
7.4.3. Bupivacaine Market
7.4.3.1. Overview
7.4.3.2. Bupivacaine Market Forecast and Analysis
7.4.4. Ropivacaine Market
7.4.4.1. Overview
7.4.4.2. Ropivacaine Market Forecast and Analysis
7.4.5. Lidocaine Market
7.4.5.1. Overview
7.4.5.2. Lidocaine Market Forecast and Analysis
7.4.6. Chloroprocaine Market
7.4.6.1. Overview
7.4.6.2. Chloroprocaine Market Forecast and Analysis
7.4.7. Articaine Market
7.4.7.1. Overview
7.4.7.2. Articaine Market Forecast and Analysis
7.4.8. Benzocaine Market
7.4.8.1. Overview
7.4.8.2. Benzocaine Market Forecast and Analysis
7.4.9. Other Local Anesthesia Drugs Market
7.4.9.1. Overview
7.4.9.2. Other Local Anesthesia Drugs Market Forecast and Analysis
8. ANESTHETICS MARKET - REVENUE AND FORECASTS TO 2028 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. INHALATION
8.3.1. Overview
8.3.2. Inhalation Market Forecast and Analysis
8.4. INJECTION
8.4.1. Overview
8.4.2. Injection Market Forecast and Analysis
8.5. OTHER ROUTES OF ADMINISTRATION
8.5.1. Overview
8.5.2. Other Routes of Administration Market Forecast and Analysis
9. ANESTHETICS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. GENERAL SURGERIES
9.3.1. Overview
9.3.2. General Surgeries Market Forecast and Analysis
9.4. PLASTIC SURGERY
9.4.1. Overview
9.4.2. Plastic Surgery Market Forecast and Analysis
9.5. COSMETIC SURGERIES
9.5.1. Overview
9.5.2. Cosmetic Surgeries Market Forecast and Analysis
9.6. DENTAL SURGERIES
9.6.1. Overview
9.6.2. Dental Surgeries Market Forecast and Analysis
9.7. OTHER APPLICATIONS
9.7.1. Overview
9.7.2. Other Applications Market Forecast and Analysis
10. ANESTHETICS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Anesthetics Market Overview
10.1.2 North America Anesthetics Market Forecasts and Analysis
10.1.3 North America Anesthetics Market Forecasts and Analysis - By Drug Type
10.1.4 North America Anesthetics Market Forecasts and Analysis - By Route Of Administration
10.1.5 North America Anesthetics Market Forecasts and Analysis - By Application
10.1.6 North America Anesthetics Market Forecasts and Analysis - By Countries
10.1.6.1 United States Anesthetics Market
10.1.6.1.1 United States Anesthetics Market by Drug Type
10.1.6.1.2 United States Anesthetics Market by Route Of Administration
10.1.6.1.3 United States Anesthetics Market by Application
10.1.6.2 Canada Anesthetics Market
10.1.6.2.1 Canada Anesthetics Market by Drug Type
10.1.6.2.2 Canada Anesthetics Market by Route Of Administration
10.1.6.2.3 Canada Anesthetics Market by Application
10.1.6.3 Mexico Anesthetics Market
10.1.6.3.1 Mexico Anesthetics Market by Drug Type
10.1.6.3.2 Mexico Anesthetics Market by Route Of Administration
10.1.6.3.3 Mexico Anesthetics Market by Application
10.2. EUROPE
10.2.1 Europe Anesthetics Market Overview
10.2.2 Europe Anesthetics Market Forecasts and Analysis
10.2.3 Europe Anesthetics Market Forecasts and Analysis - By Drug Type
10.2.4 Europe Anesthetics Market Forecasts and Analysis - By Route Of Administration
10.2.5 Europe Anesthetics Market Forecasts and Analysis - By Application
10.2.6 Europe Anesthetics Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Anesthetics Market
10.2.6.1.1 Germany Anesthetics Market by Drug Type
10.2.6.1.2 Germany Anesthetics Market by Route Of Administration
10.2.6.1.3 Germany Anesthetics Market by Application
10.2.6.2 France Anesthetics Market
10.2.6.2.1 France Anesthetics Market by Drug Type
10.2.6.2.2 France Anesthetics Market by Route Of Administration
10.2.6.2.3 France Anesthetics Market by Application
10.2.6.3 Italy Anesthetics Market
10.2.6.3.1 Italy Anesthetics Market by Drug Type
10.2.6.3.2 Italy Anesthetics Market by Route Of Administration
10.2.6.3.3 Italy Anesthetics Market by Application
10.2.6.4 Spain Anesthetics Market
10.2.6.4.1 Spain Anesthetics Market by Drug Type
10.2.6.4.2 Spain Anesthetics Market by Route Of Administration
10.2.6.4.3 Spain Anesthetics Market by Application
10.2.6.5 United Kingdom Anesthetics Market
10.2.6.5.1 United Kingdom Anesthetics Market by Drug Type
10.2.6.5.2 United Kingdom Anesthetics Market by Route Of Administration
10.2.6.5.3 United Kingdom Anesthetics Market by Application
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Anesthetics Market Overview
10.3.2 Asia-Pacific Anesthetics Market Forecasts and Analysis
10.3.3 Asia-Pacific Anesthetics Market Forecasts and Analysis - By Drug Type
10.3.4 Asia-Pacific Anesthetics Market Forecasts and Analysis - By Route Of Administration
10.3.5 Asia-Pacific Anesthetics Market Forecasts and Analysis - By Application
10.3.6 Asia-Pacific Anesthetics Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Anesthetics Market
10.3.6.1.1 Australia Anesthetics Market by Drug Type
10.3.6.1.2 Australia Anesthetics Market by Route Of Administration
10.3.6.1.3 Australia Anesthetics Market by Application
10.3.6.2 China Anesthetics Market
10.3.6.2.1 China Anesthetics Market by Drug Type
10.3.6.2.2 China Anesthetics Market by Route Of Administration
10.3.6.2.3 China Anesthetics Market by Application
10.3.6.3 India Anesthetics Market
10.3.6.3.1 India Anesthetics Market by Drug Type
10.3.6.3.2 India Anesthetics Market by Route Of Administration
10.3.6.3.3 India Anesthetics Market by Application
10.3.6.4 Japan Anesthetics Market
10.3.6.4.1 Japan Anesthetics Market by Drug Type
10.3.6.4.2 Japan Anesthetics Market by Route Of Administration
10.3.6.4.3 Japan Anesthetics Market by Application
10.3.6.5 South Korea Anesthetics Market
10.3.6.5.1 South Korea Anesthetics Market by Drug Type
10.3.6.5.2 South Korea Anesthetics Market by Route Of Administration
10.3.6.5.3 South Korea Anesthetics Market by Application
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Anesthetics Market Overview
10.4.2 Middle East and Africa Anesthetics Market Forecasts and Analysis
10.4.3 Middle East and Africa Anesthetics Market Forecasts and Analysis - By Drug Type
10.4.4 Middle East and Africa Anesthetics Market Forecasts and Analysis - By Route Of Administration
10.4.5 Middle East and Africa Anesthetics Market Forecasts and Analysis - By Application
10.4.6 Middle East and Africa Anesthetics Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Anesthetics Market
10.4.6.1.1 South Africa Anesthetics Market by Drug Type
10.4.6.1.2 South Africa Anesthetics Market by Route Of Administration
10.4.6.1.3 South Africa Anesthetics Market by Application
10.4.6.2 Saudi Arabia Anesthetics Market
10.4.6.2.1 Saudi Arabia Anesthetics Market by Drug Type
10.4.6.2.2 Saudi Arabia Anesthetics Market by Route Of Administration
10.4.6.2.3 Saudi Arabia Anesthetics Market by Application
10.4.6.3 U.A.E Anesthetics Market
10.4.6.3.1 U.A.E Anesthetics Market by Drug Type
10.4.6.3.2 U.A.E Anesthetics Market by Route Of Administration
10.4.6.3.3 U.A.E Anesthetics Market by Application
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Anesthetics Market Overview
10.5.2 South and Central America Anesthetics Market Forecasts and Analysis
10.5.3 South and Central America Anesthetics Market Forecasts and Analysis - By Drug Type
10.5.4 South and Central America Anesthetics Market Forecasts and Analysis - By Route Of Administration
10.5.5 South and Central America Anesthetics Market Forecasts and Analysis - By Application
10.5.6 South and Central America Anesthetics Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Anesthetics Market
10.5.6.1.1 Brazil Anesthetics Market by Drug Type
10.5.6.1.2 Brazil Anesthetics Market by Route Of Administration
10.5.6.1.3 Brazil Anesthetics Market by Application
10.5.6.2 Argentina Anesthetics Market
10.5.6.2.1 Argentina Anesthetics Market by Drug Type
10.5.6.2.2 Argentina Anesthetics Market by Route Of Administration
10.5.6.2.3 Argentina Anesthetics Market by Application
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ANESTHETICS MARKET, KEY COMPANY PROFILES
12.1. BAXTER
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. HOSPIRA
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ABBOTT LABORATORIES
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. ASTRAZENECA
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. F. HOFFMANN-LA ROCHE AG
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. B. BRAUN MELSUNGEN AG
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. ABBVIE INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. BOEHRINGER INGELHEIM INTERNATIONAL GMBH
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. EISAI CO. LTD
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. FRESENIUS SE AND CO. KGAA
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. Baxter
2. Hospira
3. Abbott Laboratories
4. AstraZeneca
5. F. Hoffmann-La Roche AG
6. B. Braun Melsungen AG
7. AbbVie Inc.
8. Boehringer Ingelheim International GmbH
9. Eisai Co. Ltd
10. Fresenius SE & Co. KGaA
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.